Cargando…

A population-based study in synchronous versus metachronous metastatic esophagogastric adenocarcinoma

BACKGROUND: Real-world data on treatment and outcomes in patients with synchronous metastatic disease compared with patients with metachronous metastatic disease in esophagogastric cancer have not been published before. The aim of our study was to explore treatment, overall survival (OS), and time t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pape, Marieke, Vissers, Pauline A. J., Bertwistle, David, McDonald, Laura, Slingerland, Marije, Haj Mohammad, Nadia, Beerepoot, Laurens V., Ruurda, Jelle P., Nieuwenhuijzen, Grard A. P., Jeene, Paul M., van Laarhoven, Hanneke W. M., Verhoeven, Rob H. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958715/ https://www.ncbi.nlm.nih.gov/pubmed/35356260 http://dx.doi.org/10.1177/17588359221085557

Ejemplares similares

Long-term health-related quality of life in patients with advanced esophagogastric cancer receiving first-line systemic therapy
por: Pape, Marieke, et al.
Publicado: (2023)

Heterogeneity of first‐line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real‐world evidence study
por: Dijksterhuis, Willemieke P.M., et al.
Publicado: (2019)

Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer
por: Pape, Marieke, et al.
Publicado: (2022)

A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the Netherlands
por: Pape, Marieke, et al.
Publicado: (2023)

Incidence, Stage, Treatment, and Survival of Noncardia Gastric Cancer
por: van Velzen, Merel J. M., et al.
Publicado: (2023)

Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study
por: Kroese, Tiuri E., et al.
Publicado: (2022)

SOURCE beyond first‐line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first‐line palliative systemic therapy
por: Kuijper, Steven C., et al.
Publicado: (2022)

A population-based study in resected esophageal or gastroesophageal junction cancer aligned with CheckMate 577
por: Pape, Marieke, et al.
Publicado: (2022)

Treatment patterns and survival in advanced unresectable esophageal squamous cell cancer: A population‐based study
por: Pape, Marieke, et al.
Publicado: (2022)

Comparing treatment and outcomes in advanced esophageal, gastroesophageal junction, and gastric adenocarcinomas: a population-based study
por: Pape, Marieke, et al.
Publicado: (2023)

Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study
por: Dijksterhuis, Willemieke P. M., et al.
Publicado: (2020)

Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study
por: Luijten, J. C. H. B. M., et al.
Publicado: (2022)

Treatment decision‐making during outpatient clinic visit of patients with esophagogastric cancer. The perspectives of clinicians and patients, a mixed method, multiple case study
por: Luijten, Josianne C. H. B. M., et al.
Publicado: (2022)

Trends in treatment and overall survival among patients with proximal esophageal cancer
por: de Vos-Geelen, Judith, et al.
Publicado: (2019)

The Value of Paratracheal Lymphadenectomy in Esophagectomy for Adenocarcinoma of the Esophagus or Gastroesophageal Junction: A Systematic Review of the Literature
por: Gantxegi, Amaia, et al.
Publicado: (2021)

Minimally invasive esophagectomy: a propensity score-matched analysis of semiprone versus prone position
por: Seesing, Maarten F. J., et al.
Publicado: (2017)

A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)
por: Stroes, Charlotte I, et al.
Publicado: (2022)

Endoscopic therapy replaces surgery for clinical T1 oesophageal cancer in the Netherlands: a nationwide population-based study
por: Noordzij, Irma C., et al.
Publicado: (2023)

ASO Author Reflections: Modern-Day Implementation of Robotic Esophagogastric Cancer Surgery
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer
por: Doeve, Benthe H., et al.
Publicado: (2023)

Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature
por: ter Veer, Emil, et al.
Publicado: (2016)

Robotic Techniques in Esophagogastric Cancer Surgery: An Assessment of Short- and Long-Term Clinical Outcomes
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

The different clonal origins of metachronous and synchronous metastases
por: Gofrit, Ofer N., et al.
Publicado: (2023)

Study protocol for the nutritional route in oesophageal resection trial: a single-arm feasibility trial (NUTRIENT trial)
por: Weijs, Teus J, et al.
Publicado: (2014)

Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review
por: ter Veer, Emil, et al.
Publicado: (2018)

Distal Versus Total D2-Gastrectomy for Gastric Cancer: a Secondary Analysis of Surgical and Oncological Outcomes Including Quality of Life in the Multicenter Randomized LOGICA-Trial
por: de Jongh, Cas, et al.
Publicado: (2023)

A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX
por: Stroes, Charlotte I., et al.
Publicado: (2021)

Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy
por: Dijksterhuis, Willemieke P.M., et al.
Publicado: (2019)

Isolated metachronous splenic metastasis from synchronous colon cancer
por: Gencosmanoglu, Rasim, et al.
Publicado: (2006)

Multicentric Giant Cell Tumor of Bone: Synchronous and Metachronous Presentation
por: Wirbel, Reiner, et al.
Publicado: (2013)

Metachronous gastric metastasis from lung primary, with synchronous pancreatic neuroendocrine carcinoma
por: El Hajj, Ihab I., et al.
Publicado: (2018)

Feasibility of CT radiomics to predict treatment response of individual liver metastases in esophagogastric cancer patients
por: Klaassen, Remy, et al.
Publicado: (2018)

Effects of exercise after oesophagectomy on body composition and adequacy of energy and protein intake: PERFECT multicentre randomized controlled trial
por: Hiensch, Anouk, et al.
Publicado: (2023)

Synchronous Metastatic Clear Cell Renal Cell Carcinoma to the Gallbladder With Metachronous Contralateral Recurrence
por: Pierce, Daniel P, et al.
Publicado: (2021)

Interactions in the aetiology, presentation and management of synchronous and metachronous adenocarcinoma of the prostate and rectum
por: Nash, GF, et al.
Publicado: (2012)

Metachronous or synchronous male breast and prostate cancers a duality to lookout for.
por: Mukendi, Alain Mwamba, et al.
Publicado: (2019)

Surgical resection of synchronous and metachronous lung and liver metastases of colorectal cancers
por: Jeong, Shinseok, et al.
Publicado: (2017)

Gastric xanthoma is a predictive marker for metachronous and synchronous gastric cancer
por: Shibukawa, Narihiro, et al.
Publicado: (2017)

Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors
por: Lv, Meng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ele9vmip26hmvnsq0iuha8cgpl